search
Back to results

Driving Pressure Variation: NAVA vs PSV (DPNAVA)

Primary Purpose

Mechanical Ventilation Complication, Ventilator-Induced Lung Injury

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
NAVAPSV
Sponsored by
Azienda Ospedaliero Universitaria Maggiore della Carita
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Mechanical Ventilation Complication focused on measuring PSV, NAVA, Driving Pressure, Mechanical Assisted Ventilation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >18 years
  • Every patients undergoing partial assisted mechanical ventilation

Exclusion Criteria:

  • Gastro-esophageal surgery in the previous 12 months;
  • Gastro-esophageal bleeding in the previous 30 days;
  • Esophageal varices history;
  • Maxillo-facial surgery or trauma;
  • Haemodinamic instability despite adequate fluid infusion (i.e. need for continuous infusion epinephrine or vasopressin or dopamine at a dose greater than 5 mcg/kg/min to obtain systolic pressure > 90 mmHg);
  • Body temperature > 38° C during the study screening;
  • Coagulation disorders (INR > 1.5, aPTT > 44 sec);
  • Vt < 8 ml/kg with minimum inspiratory effort of 8 cmH2O;
  • Inclusion in other research protocols

Sites / Locations

  • A.O.U Maggiore della CaritàRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

NAVAPSV

Arm Description

Each patient enrolled in the study will be submitted to 3 ventilation trials during PSV and NAVA ventilation modes, assigned in a randomized order.

Outcomes

Primary Outcome Measures

Driving pressure in PSV and NAVA
Driving Pressure measurements in in PSV and NAVA (cmH2O)

Secondary Outcome Measures

Respiratory mechanical indices variation
electrical diaphragmatic activity (mcvolts)
Patient/ventilator interaction
asynchrony index (normal value < 10%; pathological value > 10%)
Patient/ventilator interaction
time of synchrony (msec)
diaphragm ultrasound
evaluation of diaphragm performance at each trial

Full Information

First Posted
October 19, 2018
Last Updated
April 11, 2019
Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
search

1. Study Identification

Unique Protocol Identification Number
NCT03719365
Brief Title
Driving Pressure Variation: NAVA vs PSV
Acronym
DPNAVA
Official Title
Driving Pressure Variation During Proportional Assisted Ventilation: Comparison Between NAVA and PSV
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2018 (Actual)
Primary Completion Date
December 1, 2019 (Anticipated)
Study Completion Date
November 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Assisted ventilation represents, nowadays, the preferred ventilation mode in clinical practice.It has been shown that assisted ventilation modes improve ventilation/perfusion matching, descrease risk of Ventilator induced lung injury and muscle atrophy and have less influence on haemodynamic function. However, PSV (Pressure Support Ventilation) is not free from complications: it may worsen or cause lung injuries by increasing alveolar and intrathoracic negative pressure and by loosing control on Tidal Volume (Vt). Indeed, it has been demonstrated that Vt is the main factor related to VILI. It has been shown that lower Vt and higher PEEP can improve clinical outcome only if associated with a simultaneous reduction in Driving Pressure. Increase in Driving Pressure resulted strongly associated with negative outcomes, especially if higher than 15 cm H2O. PSV is currently the most used assisted ventilation mode. NAVA (Neurally Adjusted Ventilatory Assist) is a ventilation mode in which the diaphragmatic electrical activity (EAdi) is used as a trigger to start a mechanical breath, applying positive pressure during patient's inspiration. Diaphragmatic electrical activity (EAdi) can be detected by a particular nasogastric tube (EAdi catheter). EAdi is the currently available signal closest to the neural breathing centers, which can estimate the patient's respiratory drive, if phrenic nerves are not damaged. It has been demonstrated that NAVA ventilation can reduce the incidence of patient-ventilator asynchronies, because the delivery of the support and the cycling between inspiration and expiration are completely controlled by the patient. However, although PSV and NAVA have been widely compared in many investigations, up to now there are no studies about driving pressure variation during these two modalities of mechanical assisted ventilation. The aim of this study is to measure changes in driving pressure at different levels of ventilatory assistance in PSV and NAVA ventilation modes. Secondary end points are respiratory mechanics indices and patient/ventilator related asynchrony evaluation and comparison.
Detailed Description
Any patient who is already on an assisted mode of ventilation and displays triggering efforts will be enrolled in the study and will be submitted to 3 ventilation trials, in PSV and NAVA ventilation modes; each trial will last 20 minutes. Every trial will be performed in a randomized order, based on random computer generated sequences. During the first trial, PSV will be set in order to obtain a Vt between 6 and 8 ml/kg;this support level will be defined as PSV100. Subsequently, the corresponding NAVA level (NAVA 100) will be determined using a dedicated ventilator function (NAVA Preview) which is able to estimate NAVA level in order to deliver an equivalent inspiratory peak pressure (Paw peak) compared to that obtained during PSV mode. Afterwards, pressure support level of assistance of PSV100 and NAVA100 will be firstly increased (PSV150 and NAVA150) during the second trial and then decreased during the third trial (PSV50 and NAVA150) by 50% from basal value. During the study period, PEEP and FiO2 will be kept equal to the values in use before patient enrollment. End-inspiration and end-expiration pauses will be performed at the end of each trial by pressing the dedicated button on the ventilator control panel. Airway pressure and flow will be recorded. Patients, as usual, clinical practice, will be sedated at different levels and this could compromise their content of consciousness. At the beginning of each trial, an endotracheal tube suction will be done. Last 5 minutes of each trial will be recorded and stored in a computer for subsequent statistical analysis. Respiratory mechanical indices (airway pressure, tidal volume, flow) and electric diaphragmatic activity will be recorded by a dedicated software called NAVA- tracker. At the end of each trial an arterial blood gas analysis (ABGs) will be performed to evaluate PaCO2, PH and blood oxygenation (PaO2). at the end of each trial, an ultrasound evaluation of diaphragm will be performed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mechanical Ventilation Complication, Ventilator-Induced Lung Injury
Keywords
PSV, NAVA, Driving Pressure, Mechanical Assisted Ventilation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Randomized, interventional, prospective study
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
NAVAPSV
Arm Type
Experimental
Arm Description
Each patient enrolled in the study will be submitted to 3 ventilation trials during PSV and NAVA ventilation modes, assigned in a randomized order.
Intervention Type
Device
Intervention Name(s)
NAVAPSV
Intervention Description
During the first trial, PSV will be set in order to obtain a Vt between 6 and 8 ml/kg; this support level will be defined as PSV100. Subsequently, the corresponding NAVA level (NAVA 100) will be determined using a dedicated ventilator function (NAVA Preview) which is able to estimate NAVA level in order to deliver an equivalent inspiratory peak pressure (Paw peak) compared to that obtained during PSV mode. Afterwards, PSV100 and NAVA100 will be first increased (PSV150 and NAVA150) during the second trial and then decreased during the third trial (PSV50 and NAVA150) by 50% from basal value. During the study period, PEEP and FiO2 will be kept equal to the values in use before patient enrollment.
Primary Outcome Measure Information:
Title
Driving pressure in PSV and NAVA
Description
Driving Pressure measurements in in PSV and NAVA (cmH2O)
Time Frame
At the end of every 20 minutes lasting ventilation trial.
Secondary Outcome Measure Information:
Title
Respiratory mechanical indices variation
Description
electrical diaphragmatic activity (mcvolts)
Time Frame
At the end of every 20 minutes lasting ventilation trial.
Title
Patient/ventilator interaction
Description
asynchrony index (normal value < 10%; pathological value > 10%)
Time Frame
At the end of every 20 minutes lasting ventilation trial.
Title
Patient/ventilator interaction
Description
time of synchrony (msec)
Time Frame
At the end of every 20 minutes lasting ventilation trial.
Title
diaphragm ultrasound
Description
evaluation of diaphragm performance at each trial
Time Frame
At the end of every 20 minutes lasting ventilation trial.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >18 years Every patients undergoing partial assisted mechanical ventilation Exclusion Criteria: Gastro-esophageal surgery in the previous 12 months; Gastro-esophageal bleeding in the previous 30 days; Esophageal varices history; Maxillo-facial surgery or trauma; Haemodinamic instability despite adequate fluid infusion (i.e. need for continuous infusion epinephrine or vasopressin or dopamine at a dose greater than 5 mcg/kg/min to obtain systolic pressure > 90 mmHg); Body temperature > 38° C during the study screening; Coagulation disorders (INR > 1.5, aPTT > 44 sec); Vt < 8 ml/kg with minimum inspiratory effort of 8 cmH2O; Inclusion in other research protocols
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gianmaria Cammarota, MD, PhD
Phone
00393392669420
Email
gmcamma@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gianmaria Cammarota, MD, PhD
Organizational Affiliation
AOU Maggiore della Carità
Official's Role
Principal Investigator
Facility Information:
Facility Name
A.O.U Maggiore della Carità
City
Novara
ZIP/Postal Code
28100
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gianmaria Cammarota, MD,PhD
Phone
003903213733406
Email
gmcamma@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
11435237
Citation
Putensen C, Zech S, Wrigge H, Zinserling J, Stuber F, Von Spiegel T, Mutz N. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med. 2001 Jul 1;164(1):43-9. doi: 10.1164/ajrccm.164.1.2001078.
Results Reference
background
PubMed Identifier
10194172
Citation
Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1241-8. doi: 10.1164/ajrccm.159.4.9806077.
Results Reference
background
PubMed Identifier
18079496
Citation
Grasso F, Engelberts D, Helm E, Frndova H, Jarvis S, Talakoub O, McKerlie C, Babyn P, Post M, Kavanagh BP. Negative-pressure ventilation: better oxygenation and less lung injury. Am J Respir Crit Care Med. 2008 Feb 15;177(4):412-8. doi: 10.1164/rccm.200707-1004OC. Epub 2007 Dec 13.
Results Reference
background
PubMed Identifier
24722174
Citation
Xia J, Zhang H, Sun B, Yang R, He H, Zhan Q. Spontaneous breathing with biphasic positive airway pressure attenuates lung injury in hydrochloric acid-induced acute respiratory distress syndrome. Anesthesiology. 2014 Jun;120(6):1441-9. doi: 10.1097/ALN.0000000000000259.
Results Reference
background
PubMed Identifier
18786263
Citation
Futier E, Constantin JM, Combaret L, Mosoni L, Roszyk L, Sapin V, Attaix D, Jung B, Jaber S, Bazin JE. Pressure support ventilation attenuates ventilator-induced protein modifications in the diaphragm. Crit Care. 2008;12(5):R116. doi: 10.1186/cc7010. Epub 2008 Sep 11.
Results Reference
background
PubMed Identifier
22430241
Citation
Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med. 2012 May;40(5):1578-85. doi: 10.1097/CCM.0b013e3182451c40.
Results Reference
background
PubMed Identifier
24199628
Citation
Yoshida T, Torsani V, Gomes S, De Santis RR, Beraldo MA, Costa EL, Tucci MR, Zin WA, Kavanagh BP, Amato MB. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med. 2013 Dec 15;188(12):1420-7. doi: 10.1164/rccm.201303-0539OC.
Results Reference
background
PubMed Identifier
23263584
Citation
Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. The comparison of spontaneous breathing and muscle paralysis in two different severities of experimental lung injury. Crit Care Med. 2013 Feb;41(2):536-45. doi: 10.1097/CCM.0b013e3182711972.
Results Reference
background
PubMed Identifier
9449727
Citation
Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998 Feb 5;338(6):347-54. doi: 10.1056/NEJM199802053380602.
Results Reference
background
PubMed Identifier
10793162
Citation
Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.
Results Reference
background
PubMed Identifier
17855672
Citation
Malhotra A. Low-tidal-volume ventilation in the acute respiratory distress syndrome. N Engl J Med. 2007 Sep 13;357(11):1113-20. doi: 10.1056/NEJMct074213.
Results Reference
background
PubMed Identifier
21156950
Citation
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, Vivaldi N, Malacarne P, Del Gaudio P, Livigni S, Zavala E, Filippini C, Martin EL, Donadio PP, Mastromauro I, Ranieri VM. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010 Dec 15;304(23):2620-7. doi: 10.1001/jama.2010.1796.
Results Reference
background
PubMed Identifier
23093163
Citation
Serpa Neto A, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Pasqualucci Mde O, Damasceno MC, Schultz MJ. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24;308(16):1651-9. doi: 10.1001/jama.2012.13730.
Results Reference
background
PubMed Identifier
23902482
Citation
Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B, Verzilli D, Leone M, De Jong A, Bazin JE, Pereira B, Jaber S; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013 Aug 1;369(5):428-37. doi: 10.1056/NEJMoa1301082.
Results Reference
background
PubMed Identifier
25693014
Citation
Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard JC, Carvalho CR, Brower RG. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015 Feb 19;372(8):747-55. doi: 10.1056/NEJMsa1410639.
Results Reference
background
PubMed Identifier
3698697
Citation
MacIntyre NR. Respiratory function during pressure support ventilation. Chest. 1986 May;89(5):677-83. doi: 10.1378/chest.89.5.677.
Results Reference
background
PubMed Identifier
3619200
Citation
Brochard L, Pluskwa F, Lemaire F. Improved efficacy of spontaneous breathing with inspiratory pressure support. Am Rev Respir Dis. 1987 Aug;136(2):411-5. doi: 10.1164/ajrccm/136.2.411.
Results Reference
background
PubMed Identifier
10834664
Citation
Cereda M, Foti G, Marcora B, Gili M, Giacomini M, Sparacino ME, Pesenti A. Pressure support ventilation in patients with acute lung injury. Crit Care Med. 2000 May;28(5):1269-75. doi: 10.1097/00003246-200005000-00002.
Results Reference
background
PubMed Identifier
9032512
Citation
Nava S, Bruschi C, Fracchia C, Braschi A, Rubini F. Patient-ventilator interaction and inspiratory effort during pressure support ventilation in patients with different pathologies. Eur Respir J. 1997 Jan;10(1):177-83. doi: 10.1183/09031936.97.10010177.
Results Reference
background
PubMed Identifier
10806138
Citation
Esteban A, Anzueto A, Alia I, Gordo F, Apezteguia C, Palizas F, Cide D, Goldwaser R, Soto L, Bugedo G, Rodrigo C, Pimentel J, Raimondi G, Tobin MJ. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med. 2000 May;161(5):1450-8. doi: 10.1164/ajrccm.161.5.9902018.
Results Reference
background
PubMed Identifier
20083921
Citation
Spahija J, de Marchie M, Albert M, Bellemare P, Delisle S, Beck J, Sinderby C. Patient-ventilator interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med. 2010 Feb;38(2):518-26. doi: 10.1097/CCM.0b013e3181cb0d7b.
Results Reference
background
PubMed Identifier
29115949
Citation
Ferreira JC, Diniz-Silva F, Moriya HT, Alencar AM, Amato MBP, Carvalho CRR. Neurally Adjusted Ventilatory Assist (NAVA) or Pressure Support Ventilation (PSV) during spontaneous breathing trials in critically ill patients: a crossover trial. BMC Pulm Med. 2017 Nov 7;17(1):139. doi: 10.1186/s12890-017-0484-5.
Results Reference
background
PubMed Identifier
17356084
Citation
Sinderby C, Beck J, Spahija J, de Marchie M, Lacroix J, Navalesi P, Slutsky AS. Inspiratory muscle unloading by neurally adjusted ventilatory assist during maximal inspiratory efforts in healthy subjects. Chest. 2007 Mar;131(3):711-717. doi: 10.1378/chest.06-1909.
Results Reference
background
PubMed Identifier
33559864
Citation
Cammarota G, Verdina F, De Vita N, Boniolo E, Tarquini R, Messina A, Zanoni M, Navalesi P, Vetrugno L, Bignami E, Corte FD, De Robertis E, Santangelo E, Vaschetto R. Effects of Varying Levels of Inspiratory Assistance with Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist on Driving Pressure in Patients Recovering from Hypoxemic Respiratory Failure. J Clin Monit Comput. 2022 Apr;36(2):419-427. doi: 10.1007/s10877-021-00668-2. Epub 2021 Feb 9.
Results Reference
derived

Learn more about this trial

Driving Pressure Variation: NAVA vs PSV

We'll reach out to this number within 24 hrs